{"nct_id":"NCT01614756","title":"A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis","status":"COMPLETED","status_verified_date":"2015-08","start_date":"2012-07","start_date_type":null,"primary_completion_date":"2015-04","primary_completion_date_type":"ACTUAL","completion_date":"2015-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}